Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 159 for your search:
Drug:  gefitinib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Natural history/Epidemiology, Treatment
Status: Closed
Age: 20 and over
Sponsor: Other
Protocol IDs: 9461700718, NCT00173524

2.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Completed
Age: No age specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: D791AL00002, V-15-33, OZV1533, NCT00252759

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 19 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: D7913L00067, NCT00608868

4.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D7913L00071, NCT00770588

5.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1839IL/0052 SubStudy, NCT01000740

6.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1839IL/0052, D7914C00052, NCT00684385

7.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D791AC00014, NCT01203917

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to5
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1839IL/0143, NCT00234429

9.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1839IL/0711, D7913C00711, NCT00259064

10.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor: Other
Protocol IDs: D7913L00077, NCT01579630

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ZENECA-1839IL/0014, NCT00006048

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ZENECA-1839IL/0017, MSKCC-00100, NCT00006049

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TLK286.3020, NCT00080340

14.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02956, E1302, ECOG-E1302, U10CA021115, NCT00088907

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI UNKPRI 12, NCT00193596

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D791AL00001, V-15-32, NCT00252707

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D791AC00007, Iressa Pan Asian Study (IPASS), NCT00322452

18.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000492254, NCCTG-N05C4, N05C4, NCT00362986

19.

Phase: Phase III
Type: Natural history/Epidemiology, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1839IL/0555, D7913L00008, NCT00357734

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: NCCCTS-05-126, D7913L00054, NCT00455936

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: ONC-2008-001, NCT00807066

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1839IL/0704, EudraCT no.2004-002662-38, NCT00206219

23.

Phase: Phase III
Type: Prevention, Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other
Protocol IDs: KROG-4-2008-0276, 4-2008-0276, NCT00955695

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-03041, S0023, U10CA032102, CDR0000068706, SWOG-S0023, CAN-NCIC-BR15, NCCTG-S0023, BR15, NCT00020709

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00650, SWOG-CAN-NCIC-BR19, ECOG-CAN-NCIC-BR19, BR19, CDR0000258118, CAN-NCIC-BR19, NCIC-BR.19, NCT00049543
1     
New Search